SUZHOU, China — International momentum for BIOCHINA 2027 is accelerating rapidly. Delegation groups and industry leaders from 15 countries across the globe have already confirmed their participation for Suzhou, securing early booth space and partnering passes months in advance.

As cross-border business development (BD) and face-to-face dealmaking reach an all-time high, now is the ideal time to position your brand alongside global industry leaders.

Key International Players On Board

A snapshot of key global representatives securing their spots includes:

• United States: Veristat, Zealand Pharma, Norwest
• Japan: Maruho, CMIC, Satoru Suzuki Pharma, NANO MRNA
• South Korea: KPBM Association, Incheon Technopark, Shaperon
• Switzerland & Sweden: Novartis, Embassy of Sweden in China
• Australia & Pakistan: Scindea, AUScelerate, SMCT, Matrics Research
• Other Global Hubs: Top representatives from Portugal, Russia, Canada, Italy, Belgium, Brazil, and Bangladesh

Secure Your Booth at Early Bird Rates

Don't miss the opportunity to join the world's leading biopharma players at BIOCHINA 2027. Lock in your special booth rate before the early bird window closes.

• Booth Early Bird Deadline: November 27, 2026
• Official Event Registration & Booking: https://u.morebio.cn/yQvMJntQ